XOMA CORPORATION (NASDAQ:XOMA) Files An 8-K Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| 99.1 | Press release entitled Iscalimab (CFZ533) Update |
XOMA Corp Exhibit
EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFilingEXHIBIT 99.1Iscalimab (CFZ533) Update EMERYVILLE,…
To view the full exhibit click here